drugset / Trial / NCT02322528

Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax

NCT02322528

NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to evaluate the effects of an anti-inflammatory drug (Lotemax®) on the surface of the eye and tear film (a film that coats the eye which is made up of oil and water).

Timeline

Start
2014-04
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Loteprednol Etabonate Other / unclassified

Indications